FCFE reached R$276 million in the first quarter, a record for the period. Premium brands, Ibmec and IDOMED, now account for 49% of the group’s EBITDA. The acquisition of Unifametro was completed during the quarter.
Free Cash Flow exceeds R$1 billion for the first time. The Premium segment already represents for 44% of EBITDA.